Results 31 to 40 of about 1,274,904 (321)

Cardiovascular disease in SARS‐CoV‐2 infection

open access: yesClinical & Translational Immunology, 2021
Pre‐existing cardiovascular disease (CVD) increases the morbidity and mortality of COVID‐19 and is strongly associated with poor disease outcomes. However, SARS‐CoV‐2 infection can also trigger de novo acute and chronic cardiovascular disease.
Kei Sato   +5 more
doaj   +1 more source

Evolutionary Dynamics and Dissemination Pattern of the SARS-CoV-2 Lineage B.1.1.33 During the Early Pandemic Phase in Brazil

open access: yesFrontiers in Microbiology, 2021
A previous study demonstrates that most of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Brazilian strains fell in three local clades that were introduced from Europe around late February 2020.
Paola Cristina Resende   +29 more
doaj   +1 more source

Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2 [PDF]

open access: yes, 2020
Background and purpose Infections with coronaviruses are not always confined to the respiratory tract and various neurological manifestations have been reported.
Boon, Paul   +6 more
core   +2 more sources

Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2

open access: yesAdvanced Science, 2020
The world is currently experiencing a global pandemic caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which causes severe respiratory disease similar to SARS.
Yetian Dong   +4 more
doaj   +1 more source

Racing for a SARS‐CoV‐2 vaccine

open access: yesEMBO Molecular Medicine, 2021
Graphical Abstract Interview with EMBO Members Özlem Türeci and Uğur Şahin, BioNTech, conducted by science journalist Kai Kupferschmidt.
Özlem Türeci, Uğur Şahin
doaj   +1 more source

Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern. The fragile balance between infections and autoimmunity [PDF]

open access: yes, 2020
On 7 January 2020, researchers isolated and sequenced in China from patients with severe pneumonitis a novel coronavirus, then called SARS-CoV-2, which rapidly spread worldwide, becoming a global health emergency.
Diamanti, A. P.   +4 more
core   +2 more sources

Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China

open access: yesAllergy. European Journal of Allergy and Clinical Immunology, 2020
Coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection has been widely spread. We aim to investigate the clinical characteristic and allergy status of patients infected with SARS‐CoV‐2.
Jin-Jin Zhang   +7 more
semanticscholar   +1 more source

Radiographic findings of SARS‐CoV‐2 infection

open access: yesJournal of the American College of Emergency Physicians Open, 2021
Study objective The 2019–20 coronavirus pandemic is caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which causes coronavirus disease 2019 (COVID‐19).
Catherine A. Marco   +9 more
doaj   +1 more source

Structural basis of receptor recognition by SARS-CoV-2

open access: yesNature, 2020
A novel severe acute respiratory syndrome (SARS)-like coronavirus (SARS-CoV-2) recently emerged and is rapidly spreading in humans, causing COVID-19 1 , 2 . A key to tackling this pandemic is to understand the receptor recognition mechanism of the virus,
J. Shang   +8 more
semanticscholar   +1 more source

Subacute thyroiditis after SARS‐CoV‐2 infection

open access: yesClinical Case Reports, 2021
Viral infections are considered as etiologic factors of subacute thyroiditis. The true incidence of subacute thyroiditis, caused by SARS‐CoV‐2 infection, is probably considerable since it is often masked by more dramatic affection of the respiratory ...
Vasiliy I. Semikov   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy